A randomized, placebo- and active-controlled, multi-country, multi-center parallel group trial to evaluate the efficacy and safety of a fixed-dose combination of 400 mg ibuprofen and 100 mg caffeine compared with ibuprofen 400 mg and placebo in patients with acute lower back or neck pain. [electronic resource]
Publication details: Journal of pain research 2019Description: 2771-2783 p. digitalISSN:- 1178-7090
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.